epiH Search


Epidemiol Health > Volume 33; 2011 > Article
Kim, Oh, Kim, Seo, Shin, Song, Yang, Foxman, and Ki: Risk Factors for Group B Streptococcus Colonization Among Pregnant Women in Korea



To identify obstetric and maternal factors related to Group B Streptococcus (GBS) colonization in pregnant women in Korea.


The study was conducted between the years 2006-2008 in four hospitals, Cheil and Eulji hospital in Seoul, and Motae and Eulji hospital in Daejeon. We recruited 2,644 pregnant women between 35 to 37 weeks of gestation who had visited for antenatal care. Participants completed a questionnaire, and urine, vaginal and rectal specimens were obtained and cultured using selective broth media. After delivery, medical records were reviewed.


GBS colonization was significantly associated with hospital, age group, education, frequency of pregnancy, and premature rupture of membranes (PROM, more than 18 hours). After adjustment for other variables, Cheil hospital (odds ratio [OR], 2.05; 95% confidence interval [CI], 1.20-3.52), and the first pregnancy (OR, 2.32; 95% CI, 1.12-4.81) remained significant. History of vaginitis showed marginal significance (OR, 1.50; 95% CI, 0.98-2.29).


To prevent GBS infection of neonates, clinicians should be alert to the potentially higher risk of GBS colonization in pregnant women in their first pregnancy, and women with premature rupture of membranes (PROM) (18 hours+) or who have a history of vaginitis.


Group B streptococcus (GBS, Streptococcus agalactiae) was recognized as a major cause of neonatal sepsis and meningitis in the 1970s [1], but the first Korean case of GBS neonatal meningitis was not described until 1984. Since then, the number of reported cases of neonatal GBS disease in Korea has increased steadily [2].
Neonatal sepsis usually develops within 3 days after birth, and the most frequent causative organism is GBS [3]. The main source of neonatal infection is maternal genital tract colonization [4]. GBS is transmitted vertically during labor and delivery, and colonization occurs in up to 80% of neonates born to colonized mothers [5]. Maternal streptococcal colonization is also associated with increased risk of urinary tract infection and pregnancy complications, such as endometritis [3], chorioamnionitis [3,6], preterm birth and intrauterine death [7].
Asymptomatic colonization with GBS is common worldwide, and depending on the population, between 6.5% [8] and 43.6% [9] of pregnant women are colonized with GBS in the vagina or rectum. Maternal GBS colonization varies by population characteristics such as age, parity, socio-economic status, geographic location [10], presence of sexually transmitted diseases [11] and sexual behavior [12].
The known risk factors of GBS colonization are as follows; delivery at <37 weeks' gestation, intrapartum temperature ≥38.0℃, or rupture of membranes for ≥18 hours [13]. After conducting a large population-based study, the Centers for Disease Control and Prevention (CDC) of the United States currently recommends screening of all pregnant women for GBS between 35 and 37 weeks of gestation [14]. For those with cultures positive for GBS, intrapartum antibiotic prophylaxis (IAP) during labor is recommended. Since this strategy was implemented, there has been a 70% reduction in neonatal early-onset sepsis [15].
Despite declines in early-onset GBS infection in the United States, GBS is identified in 40% of early-onset neonatal sepsis and remains a leading cause of newborn morbidity and mortality [14,16]. However, other European countries, which do not have high GBS prevalence like USA, do not recommend screening of all pregnant women for GBS.
The incidence rate of clinically diagnosed neonatal sepsis in Korea of 30.4/1,000 live births [17] is significantly higher than the 1.8/1,000 reported for the USA [18]. What percentage of this is attributable to GBS is unknown, as GBS screening is not a standard of care in Korea.
In 2006-2008, the prevalence of GBS colonization among 2,624 pregnant women in Seoul and Daejeon in Korea was 8% [19]. Risk factors for GBS colonization in pregnant women have not been previously studied in Korea.
To identify risk factors for GBS colonization in pregnant women, we analyzed the data of 2,644 Korean pregnant women who had a screened GBS culture test at 35-37 weeks gestation.



All consenting pregnant women of 35-37 weeks of gestation seen in Daejeon, at the Eulji University Hospital or the Motae Obstetrics and Gynecology (OBGY) Clinic, or in Seoul, at the Eulji General Hospital or Cheil Women's Hospital between January 2006 and May 2008 who had routine prenatal testing were included.
GBS was cultured and identified in the Departments of Laboratory Medicine of the Eulji hospitals in Seoul and Daejeon and, for samples obtained at Cheil Hospital, in the Seoul Clinical Laboratory. The laboratory also carried out antimicrobial resistance testing. The Department of Preventive Medicine of Eulji University performed GBS laboratory work for the Motae OBGY Clinic in Daejeon. The Institutional Review Boards at the Eulji (04-08 and 06-25) and Cheil (SCH-IRB-2005-24) hospitals approved the study protocol. Written informed consent permitting use of the sample materials and medical records for research purposes was obtained from every study participant.

Questionnaire & medical record

Participants completed a self-reported questionnaire, which included questions on weight and height before or after pregnancy, symptoms during last two weeks, past history, the number of prenatal examinations, state of health, the presence of antibiotics-taking, food intake during last two weeks, smoking, alcohol intake, education and household monthly income. We reviewed medical records following delivery to collect gravidity, complications during the pregnancy, delivery type, the presence of ruptured membranes, and duration of membrane rupture. Gravidity indicates the total number of times a woman has been pregnant, regardless of whether these pregnancies were carried to term. The current pregnancy was included in the count.

GBS isolates

GBS collection

Physicians collected vaginal mucus or discharge with a swab from the vaginal introitus without inserting a speculum, and placed the swab into Stuart's transport medium. A swab was inserted through the anal sphincter, rotated two or three times, and placed into a separate container of transport medium. Urine samples were self-collected specimens of the first 20 mL of urine. All participating laboratories used the same protocols for sample collection, GBS incubation and identification. Media and reagents were purchased by the combined research team and distributed to each participating laboratory.

GBS culture

Todd-Hewitt broth supplemented either with gentamicin (8 µg/mL) and nalidixic acid (15 µg/mL), or with colistin (10 µg/mL) and nalidixic acid (15 µg/mL) was used to repress the growth of microorganisms other than GBS. Urine samples were centrifuged, and 1 mL of the sedimented sample was placed into the selective medium. Rectal and vaginal swabs were removed from the transport medium and used to inoculate the selective broth medium. Cultures were shaken three or four times to ensure adequate mixing of the analyte. The lids of the culture tubes were loosely closed and the cultures incubated, along with a negative control, for 18-24 hours at 35-37℃ in ambient air containing 5% CO2. If the medium in the tubes was still clear after 18-24 hours, the cultures were reincubated and inspected again at 48 hours. Specimens with evident bacterial growth were subcultured on plates containing sheep blood agar, that is, a tryptic soy agar with 5% defibrinated sheep blood (TSAII; KOMED Co., Sungnam, Korea).

GBS identification

We used a catalase test followed by a latex agglutination assay (Streptex; Murex Biotech Ltd., Dartford, England) to confirm the isolate was GBS.

Statistical analysis

All statistical analyses were done using SPSS version 18.0 (SPSS Inc., Chicago, IL, USA). The relationship between GBS colonization and various risk factors were tested for statistical significance using the chi-square test, test for trend, and multiple logistic regression models.


GBS colonization by demographic characteristics

The overall prevalence of GBS colonization among pregnant women at 35-37 weeks of gestation was 8.3% (219/2,644). Women <25 years had higher rates (14.0%), as did women identified at the Cheil hospital (10.7%). GBS colonization increased significantly with increasing education (p=0.034), but monthly income was not associated with GBS colonization. Smoking, alcohol intake during pregnancy, body mass index (BMI) before pregnancy, and subjective health status during pregnancy also were not associated with GBS colonization (Table 1).

GBS colonization by obstetric characteristics

Women with one or more children or a history of two or more abortions had a significantly lower prevalence of GBS colonization (p=0.045 and p=0.034, respectively). This is consistent with pregnancy history: higher gravidity was associated with lower prevalence of GBS colonization (p=0.009). Delivery type, having antibiotics before GBS screening, number of prenatal vaginal examinations, and vaginal sonography were not related to GBS colonization. Although the association with premature rupture of membranes (PROM) was not significant, membrane rupture of greater than 18 hours was marginally associated with increased prevalence of GBS colonization (p=0.079), (Table 2).

GBS colonization by symptoms and diseases

GBS prevalence was not associated with self-reported history for upper respiratory or gastrointestinal symptoms during the last 2 weeks. Among complications occurring during the current pregnancy, only a history of urinary tract infection was significantly related to GBS colonization (p<0.001). Self-reported lifetime histories of selected infectious and non-infectious diseases were not significantly associated with GBS colonization (Table 3).

GBS colonization by food intake frequency

Regarding the frequency of food intake during last two weeks before the GBS test, drinking milk six or more time was significantly associated with GBS colonization (p=0.043). However fruits, vegetables, egg, chicken, pork, beef, raw fish and cooked fish, were not significantly associated with GBS colonization (Table 4).

Risk factors for GBS colonization after adjustment using a multiple logistic regression model

All variables significant in the univariate analysis were included in a multiple regression model. After adjustment for hospital, age, gravidity, history of vaginitis and cystitis, associations with education level and frequency of drinking milk were no longer statistically significant. History of urinary tract infection and the duration of PROM over 18 hours were not included in the model because the sample size of urinary tract infection was very small (n=15) and only PROM positives have a duration of PROM.
Following adjustment, Cheil hospital (OR, 2.05; 95% CI, 1.20-3.52) and the first pregnancy (OR, 2.32; 95% CI, 1.12-4.81) were significantly associated with GBS colonization (Motae hospital, which is a private clinic for obstetrics, does not record abortions, so the cases from this hospital were not included in multiple regression analysis.). The history of vaginitis and cystitis were marginally significant, however, vaginitis increased colonization and cystitis decreased colonization. Women under 25 years had a higher colonization rate compared to women 35 years and older, but women 25 to 29 years old had a significantly lower prevalence. An interaction between age group and gravidity was not statistically significant; the interaction term was not included in the final model (Table 5).


Among 2,644 pregnant Korean women screened between 35-37 weeks gestation, GBS colonization was significantly higher in the first pregnancy, and in one hospital.
Women less than 25 years of age had a higher prevalence of colonization, but there was no linear trend with age, and younger age was not a significant risk factor following adjustment. An association between age and gravidity and GBS colonization has been reported in some studies but not others; several studies [20-22] found no significant differences in colonization rates by age or parity, while others report associations with increasing gravidity [23], young age [24] and lower parity [10,24,25].
In other countries, young maternal age is a risk factor for early-onset neonatal sepsis [14,24,26,27] and infants who are born of teenagers show higher rates of GBS diseases [26]. In this study, only 3.5% of study participants were less than 25 years old; therefore, if an association with maternal age exists in Korea, it is swamped by other variables in our dataset.
In contrast to other reports where GBS prevalence is higher among those with lower socioeconomic status [28] and education [10], we observed higher colonization rates among women who are socially advantaged with a higher education. However, these associations were not significant following adjustment because a higher education was related to younger age, primigravida, and Cheil hospital.
Risk factors for colonization by serotype of GBS were analyzed. After adjustment, Cheil hospital (OR, 7.51; 95% CI, 1.02-55.46) and a history of vaginitis (OR, 2.18; 95% CI, 1.00-4.75) were significantly associated with serotype V GBS colonization. For other serotypes, there were no significant variables in multiple logistic regression models (data not shown).
As the GBS is a common colonizer of the genital and rectal area, the ascent of GBS from the vagina to the amniotic fluid likely increases the risk of neonatal infection. Therefore, frequent vaginal exams [6,29] or vaginal sonogram might increase risk of PROM or preterm labor. In this study we found that a high frequency of vaginal sonography (3 times or more) significantly increased risk of PROM (OR, 1.49; 95% CI, 1.13-1.97) compared to having a sonogram 0-2 times (data not shown). However, this risk was not significantly increased among women colonized with GBS.
Even though PROM was not related to significantly higher GBS colonization rates, among PROM mothers, PROM of 18 hours or more duration was marginally associated with a high prevalence of GBS colonization (p=0.079).
Among the symptoms during last two weeks before test, there were no related symptoms found. Among diseases during pregnancy, urinary tract infection was shown as a significant risk factor. However, the prevalence of urinary tract infection was very low - 0.5% (15/2,644).
Among four participating hospitals, Cheil hospital showed high rates of GBS colonization, which was still significant even in a multiple regression analysis. Cheil hospital is well known as a maternity hospital, and has the greatest number of deliveries in Korea; some 8,000 women give birth there each year. We could not explain why the GBS colonization rate is high in Cheil hospital in this study. In comparisons of four hospitals, there were no significant differences, except GBS colonization rates.
In the U.S in 1996, CDC recommended the use of one of two prevention strategies for decreasing GBS disease: a screening-based method, where IAP is offered to women identified as GBS carriers through prenatal screening cultures collected at 35-37 weeks' gestation and to women who develop premature onset of labor or rupture of membranes at less than 37 weeks' gestation, and the other is the risk-based method, where IAP is provided to women who develop one or more risk conditions at the time of labor or membrane rupture [13]. Subsequently, in 2002, CDC recommended that all pregnant women be screened at 35-37 weeks' gestation for vaginal and rectal GBS colonization, and if the result of GBS culture is not known at the onset of labor, IAP should be administered to women with any of the following risk factors (gestation <37 weeks, duration of membrane rupture ≥18 hours, or a temperature of ≥38.0℃) [14]. In the revised guidelines of 2010, the principles were not changed [30].
In the current study, 45% of the pregnant women had one or two risk factors (<25 years, and the first pregnancy); the GBS colonization rate was 10.8% in risk group. However, the GBS colonization rate for the no-risk group was 7.3%, suggesting that a better understanding of GBS risk factors in Korea is in order before recommending a risk-based strategy.


We thank SCL (Seoul Clinical Laboratories & Seoul Medical Science Institute), and the following physicians for providing some of the isolates used in this study: Ji-Hee Yu (Motae Women's Hospital, Daejeon), Jung Yeol Han, Hyun Mee Ryu, Hyun Kyong Ahn, Jin Hoon Chung, June Seek Choi, Min Hyoung Kim and Si Won Lee (Cheil General Hospital & Women's Healthcare Center, Kwandong University, Seoul); Jun-Suk Park, In-Tack Hwang, and Jung-Hun Rho (Eulji University Hospital, Daejeon); and Seo-Yoo Hong and Won-Il Park (Eulji Hospital, Seoul).
Funding: This work was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD), (KRF-2007-313-E00172), and from the National Institutes of Health (R01 AI051675 [BF]).


Preliminary results were presented in the 61st Korean Society for Preventive Medicine Fall Meetings, Muchangpo, Korea 22-23 October 2009.


The authors have no conflicts of interest to declare for this study.


This article is available from: http://e-epih.org/.


1. Bergeron MG, Ke D, Menard C, Picard FJ, Gagnon M, Bernier M, et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 2000;343:175-179. 10900276. PMID: 10900276
crossref pmid
2. Choi KU, Koh SK, Lee JY, Park JH, Hwang SO, Lee BI, et al. Clinical significance of group B streptococcal infection in pregnant women. Korean J Obstet Gynecol 2002;45:811-815 (Korean).

3. Winn HN. Group B streptococcus infection in pregnancy. Clin Perinatol 2007;34:387-392. 17765489. PMID: 17765489
crossref pmid
4. Boyer KM, Gotoff SP. Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother 1985;35:267-280. 3931544. PMID: 3931544
crossref pmid
5. Schuchat A. Group B streptococcal disease in newborns: a global perspective on prevention. Biomed Pharmacother 1995;49:19-25. 7749075. PMID: 7749075
crossref pmid
6. Yancey MK, Duff P, Clark P, Kurtzer T, Frentzen BH, Kubilis P. Peripartum infection associated with vaginal group B streptococcal colonization. Obstet Gynecol 1994;84:816-819. 7936518. PMID: 7936518
7. Tyrrell GJ, Senzilet LD, Spika JS, Kertesz DA, Alagaratnam M, Lovgren M, et al. Sentinel Health Unit Surveillance System Site Coordinators. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. J Infect Dis 2000;182:168-173. 10882594. PMID: 10882594
crossref pmid
8. Yucesoy G, Caliskan E, Karadenizli A, Corakci A, Yucesoy I, Hüseyinoğlu N, et al. Maternal colonisation with group B streptococcus and effectiveness of a culture-based protocol to prevent early-onset neonatal sepsis. Int J Clin Pract 2004;58:735-739. 15372844. PMID: 15372844
crossref pmid
9. Gavino M, Wang E. A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization. Am J Obstet Gynecol 2007;197:388. e381-e384. 17904971. PMID: 17904971
crossref pmid
10. Regan JA, Klebanoff MA, Nugent RP. Vaginal Infections and Prematurity Study Group. The epidemiology of group B streptococcal colonization in pregnancy. Obstet Gynecol 1991;77:604-610. 2002986. PMID: 2002986
crossref pmid
11. Persson K, Bjerre B, Hansson H, Forsgren A. Several factors influencing the colonization of group B streptococci--rectum probably the main reservoir. Scand J Infect Dis 1981;13:171-175. 6797054. PMID: 6797054
crossref pmid
12. Foxman B, Gillespie BW, Manning SD, Marrs CF. Risk factors for group B streptococcal colonization: potential for different transmission systems by capsular type. Ann Epidemiol 2007;17:854-862. 17689259. PMID: 17689259
crossref pmid pmc
13. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep 1996;45:1-24.

14. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51:1-22. 12211284.

15. Baltimore RS. Consequences of prophylaxis for group B streptococcal infections of the neonate. Semin Perinatol 2007;31:33-38. 17317425. PMID: 17317425
crossref pmid
16. Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A, et al. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics 2002;110:690-695. 12359781. PMID: 12359781
crossref pmid
17. Shin YJ, Ki M, Foxman B. Epidemiology of neonatal sepsis in South Korea. Pediatr Int 2009;51:225-232. 19405921. PMID: 19405921
crossref pmid pmc
18. Sinha A, Yokoe D, Platt R. Epidemiology of neonatal infections: experience during and after hospitalization. Pediatr Infect Dis J 2003;22:244-251. 12634586. PMID: 12634586
crossref pmid
19. Lee BK, Song YR, Kim MY, Yang JH, Shin JH, Seo YS, et al. Epidemiology of group B streptococcus in Korean pregnant women. Epidemiol Infect 2010;138:292-298. 19781117. PMID: 19781117
crossref pmid
20. Baker CJ, Barrett FF, Yow MD. The influence of advancing gestation on group B streptococcal colonization in pregnant women. Am J Obstet Gynecol 1975;122:820-823. 1096618. PMID: 1096618
crossref pmid
21. Hastings MJ, Easmon CS, Neill J, Bloxham B, Rivers RP. Group B streptococcal colonisation and the outcome of pregnancy. J Infect 1986;12:23-29. 3514769. PMID: 3514769
crossref pmid
22. Valkenburg-van den Berg AW, Sprij AJ, Oostvogel PM, Mutsaers JA, Renes WB, Rosendaal FR, et al. Prevalence of colonisation with group B Streptococci in pregnant women of a multi-ethnic population in The Netherlands. Eur J Obstet Gynecol Reprod Biol 2006;124:178-183. 16026920. PMID: 16026920
crossref pmid
23. Papapetropoulou M, Kondakis XG. A study of risk factors of vaginal colonization with group B streptococci in pregnancy. Eur J Epidemiol 1987;3:419-422. 3319672. PMID: 3319672
crossref pmid
24. Anthony BF, Okada DM, Hobel CJ. Epidemiology of group B Streptococcus: longitudinal observations during pregnancy. J Infect Dis 1978;137:524-530. 351070. PMID: 351070
crossref pmid
25. Yow MD, Leeds LJ, Thompson PK, Mason EO Jr, Clark DJ, Beachler CW. The natural history of group B streptococcal colonization in the pregnant woman and her offspring. I. Colonization studies. Am J Obstet Gynecol 1980;137:34-38. 6989247. PMID: 6989247
26. Schuchat A, Oxtoby M, Cochi S, Sikes RK, Hightower A, Plikaytis B, et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 1990;162:672-677. 2201741. PMID: 2201741
crossref pmid
27. Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill KM, Mohle-Boetani J, Wenger JD. The Active Surveillance Study Group. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J 1994;13:623-629. 7970951. PMID: 7970951
crossref pmid
28. Grimwood K, Stone PR, Gosling IA, Green R, Darlow BA, Lennon DR, et al. Late antenatal carriage of group B Streptococcus by New Zealand women. Aust N Z J Obstet Gynaecol 2002;42:182-186. 12069147. PMID: 12069147
crossref pmid
29. Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O'Sullivan MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics 2000;105:21-26. 10617699. PMID: 10617699
crossref pmid
30. Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases. National Center for Immunization and Respiratory Diseases. Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59:1-36. 21088663.

Table 1
Group B streptococcus (GBS) colonization rate by demographic characteristics of pregnant women (35-37 weeks) in Korea (2006-2008)
Subjects (n) GBS positives (%) p-value*
Hospital < 0.001
 Daejeon Eulji 326 4.9
 Seoul Eulji 298 5.7
 Motae 673 6.2
 Cheil 1,347 10.7
Age (yr) 0.070
 < 25 93 14.0
 25-29 848 6.7
 30-34 1,236 8.5
 35+ 390 9.0
 Missing 77 11.7
BMI before pregnant (kg/m2) 0.868
 < 20 1,042 8.2
 20-24 1,291 8.2
 25+ 223 7.2
 Missing 88 13.6
Health status during pregnancy 0.837
 Healthy 1,743 8.4
 Moderate 725 7.9
 Not good 118 9.3
 Missing 58 8.6
Smoking during pregnancy 0.638
 Never 1,956 8.3
 Secondhand 647 8.3
 Yes 5 20.0
 Missing 36 5.6
Alcohol during pregnancy 0.681
 Never 2,297 8.4
 Yes 311 7.7
 Missing 36 5.6
Education 0.034
 High school or less 666 6.8
 College 565 7.3
 University or more 1,326 9.4
 Missing 87 10.3
Household monthly income (US$) 0.186
 <3,000 1,189 7.5
 3,000-3,999 375 9.3
 4,000-4,999 303 11.2
 5,000+ 263 8.4
 Missing 514 7.6
Total 2,644 8.3

BMI, body mass index.

1US$=1,000 Korea Won.

*p-value obtained by chi-square test; p-value obtained by trend test.

Table 2
Group B streptococcus (GBS) colonization rate by obstetric characteristics of pregnant women (35-37 weeks) in Korea (2006-2008)
Subjects (n) GBS positives (%) p-value*
No. of living baby 0.045
 0 1,724 8.8
 1+ 870 6.6
Missing 50 20.0
No. of abortion (s) 0.034
 0 1,243 9.1
 1 453 10.2
 2+ 229 4.4
 Missing 719 7.0
Gravidity 0.009
 1 853 10.4
 2-3 891 8.0
 4+ 181 5.0
 Missing 719 7.0
Antibiotics 2 weeks before test 0.567
 No 2,573 8.3
 Yes 35 8.6
 Missing 36 5.6
No. of prenatal vaginal exam (s) 0.407
 0 193 9.8
 1-2 804 7.0
 3-4 126 7.9
 5+ 84 10.7
 Missing 1,437 8.7
No. of prenatal vaginal sonogram (s) 0.210
 0 45 6.7
 1-2 662 8.8
 3-4 441 5.7
 5+ 223 9.4
 Missing 1,273 8.8
Delivery type 0.358
 Vaginal 1,896 7.9
 Cesarean section 679 9.0
 Missing 69 13.0
Premature rupture of membrane (PROM) 0.139
 No 2,057 7.8
 Yes 511 9.8
 Missing 76 11.8
Duration of PROM 0.079
 <18 hours 308 7.5
 18 hours + 134 12.7
 Missing 69 14.5

p-value obtained by *chi-square test; trend test; Fisher's exact test.

Table 3
Group B streptococcus (GBS) colonization rate (%) by symptoms during last two weeks and diseases in pregnant women (35-37 weeks) in Korea (2006-2008)
n GBS (%) n GBS (%) n GBS (%)
 Influenza-like illness 560 8.6 2,048 8.3 36 5.6 0.808
 Fever 20 5.0 2,588 8.3 36 5.6 0.589
 Sore throat 312 7.7 2,296 8.4 36 5.6 0.668
 Vomiting 103 8.7 2,505 8.3 36 5.6 0.876
 Diarrhea 278 10.4 2,330 8.1 36 5.6 0.178
Complications during pregnancy
 Hypertension 34 2.9 2,555 8.2 55 14.5 0.264
 Diabetes 70 8.6 2,519 8.1 55 14.5 0.896
 Urinary tract infection 15 40.0 2,574 8.0 55 14.5 < 0.001
 Myoma 49 8.2 2,540 8.1 55 14.5 0.997
 Oligohydramnios 138 8.7 2,451 8.1 55 14.5 0.810
 Polyhydramnios 5 0.0 2,584 8.2 55 14.5 0.356
Diseases in lifetime
 Cystitis 285 6.7 2,323 8.5 36 5.6 0.470
 Nephritis 118 6.8 2,490 8.4 36 5.6 0.689
 Vaginitis 417 10.1 2,191 8.0 36 5.6 0.307
 Herpes infection 34 14.7 2,574 8.2 36 5.6 0.332
 Diabetes 85 9.4 2,523 8.3 36 5.6 0.711
 Hypertension 25 16.0 2,583 8.2 36 5.6 0.162
 Tuberculosis 78 11.5 2,530 8.2 36 5.6 0.296
 Viral hepatitis 90 5.6 2,518 8.4 36 5.6 0.334
 Gonorrhea 8 0.0 2,600 8.3 36 5.6 0.393

*p-value obtained by chi-square test.

Table 4
Group B streptococcus (GBS) colonization rate by frequency of food intake during last two weeks in pregnant women (35-37 weeks) in Korea (2006-2008)
n GBS (%) n GBS (%) n GBS (%)
Fruits 44 4.5 728 8.1 1,812 8.5 0.624
Vegetables 175 7.4 1,320 7.7 1,029 9.4 0.301
Milk 300 7.7 881 6.7 1,379 9.6 0.043
Egg 415 9.2 1,449 7.9 677 8.9 0.598
Chicken 1,398 8.9 1,050 7.7 64 7.8 0.548
Beef 1,134 8.1 1,265 8.1 124 11.3 0.460
Pork 732 7.2 1,660 8.9 144 7.6 0.374
Raw fish 2,237 8.4 223 8.1 10 0.0 0.620
Cooked fish 952 8.3 1,402 8.3 183 9.8 0.766

*p-value obtained by chi-square test.

Table 5
Risk of Group B streptococcus (GBS) colonization in pregnant women (35-37 weeks) in Korea (2006-2008) by using a multiple logistic regression model (n=1,907)
Variables of regression model GBS positives n (%) GBS negatives n (%) Unadjusted OR Adjusted OR 95% CI p-value
 Daejeon Eulji 16 (5.2) 291 (94.8) 1.00 1.00
 Seoul Eulji 16 (5.6) 268 (94.4) 1.09 1.02 0.50-2.09 0.960
 Cheil 137 (10.4) 1,179 (89.6) 2.11 2.05 1.20-3.52 0.009
Age (yr)
 < 25 9 (18.4) 40 (81.6) 2.09 1.83 0.77-4.03 0.181
 25-29 41 (7.4) 514 (92.6) 0.74 0.58 0.35-0.94 0.028
 30-34 86 (8.9) 878 (91.1) 0.91 0.76 0.49-1.17 0.208
 35+ 33 (9.7) 306 (90.3) 1.00 1.00
 4+ 9 (5.0) 172 (95.0) 1.00 1.00
 2-3 71 (8.0) 817 (92.0) 1.66 1.62 0.79-3.35 0.192
 1 89 (10.6) 749 (89.4) 2.27 2.32 1.12-4.81 0.023
 No 139 (8.5) 1,496 (91.5) 1.00 1.00
 Yes 30 (11.8) 224 (88.2) 1.55 1.50 0.98-2.29 0.063
 No 156 (9.3) 1,521 (90.7) 1.35 1.76 0.97-3.18 0.062
 Yes 13 (6.1) 199 (93.9) 1.00 1.00


Browse all articles >

Editorial Office
Department of Preventive Medicine, Yonsei University College of Medicine
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
TEL: +82-2-745-0662   FAX: +82-2-764-8328    E-mail: office.epih@gmail.com

Copyright © 2022 by Korean Society of Epidemiology.

Developed in M2PI

Close layer
prev next